Perceptions of Trauma and Violence Informed Care

Assessment of Survivor and Provider Perceptions of Trauma and Violence Informed Care Among Black Women

The purpose of this study is to adapt, implement and evaluate a trauma and violence informed care intervention designed for Black women in middle Tennessee.

Study Overview

• Status: Recruiting
• Conditions: Intimate Partner Violence
• Intervention / Treatment: Behavioral: Educational materials

Detailed Description

The primary goal is the adaptation, implementation and evaluation of a trauma and violence informed care (TVIC) intervention designed for Black women in middle Tennessee. In this 5-year RCMI project, the investigators propose 3 aims. Aim 1) Engage a stakeholder committee of patients, providers, and experts (COPE) to adapt a TVIC intervention for Black women and their healthcare providers at Meharry. [Years 1-2]. Aim 2) Implement and prospectively evaluate the adapted TVIC intervention at the healthcare provider-level, measuring changes in Meharry healthcare provider's self-efficacy for TVIC implementation and alignment with TIC knowledge, attitudes, and practices. [Years 2-3] Aim 3) Implement the adapted TVIC intervention at the patient-level to provide trauma-informed IPV screening, brief interventions, and referrals to treatment (SBIRT), and rigorously evaluate this TVIC intervention's impact on the primary outcome of patient-perceived usefulness of intervention and reported linkage to IPV services, and the secondary outcome of changes at the clinic-level relative to climate and culture, through a non-randomized pragmatic trial design. [Year 4-5].

• Study Type: Interventional
• Enrollment (Estimated): 250
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Maureen Sanderson, PhD; Phone Number: 615-321-2977; Email: msanderson@mmc.edu

Study Locations

• United States
  • Tennessee
    • Nashville, Tennessee, United States, 37208
      • Recruiting
      • Meharry Medical College
      • Contact: Maureen Sanderson, PhD; Phone Number: 6153212977; Email: msanderson@mmc.edu

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• Meharry or Matthew Walker Comprehensive Health Center female patients
• Self-identify as Black
• Self-identify as intimate partner violence survivors
• English or Spanish language fluency

Exclusion Criteria:

• Not Black female intimate partner violence survivor of Meharry or Matthew Walker Comprehensive Health Center
• Those without English or Spanish language fluency

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: Non-Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
No Intervention: Usual Care
Experimental: TVIC Intervention	Behavioral: Educational materials; Trauma-informed intimate partner violence screening, brief interventions, and referrals to treatment by providers

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Number of patients who received appropriate intimate partner violence screening and trauma/mental health services referral	12 months

Collaborators and Investigators

• Sponsor: Meharry Medical College
• Collaborators: Matthew Walker Comprehensive Health Center

Study record dates

Study Major Dates

• Study Start (Actual): April 17, 2023
• Primary Completion (Estimated): March 31, 2027
• Study Completion (Estimated): August 31, 2027

Study Registration Dates

• First Submitted: March 14, 2023
• First Submitted That Met QC Criteria: May 3, 2023
• First Posted (Actual): May 6, 2023

Study Record Updates

• Last Update Posted (Actual): May 13, 2025
• Last Update Submitted That Met QC Criteria: May 7, 2025
• Last Verified: May 1, 2025

More Information

Terms related to this study

• Other Study ID Numbers: 22-05-1198

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No